Eric J. Hyllengren, EVP, CFO at Atara Biotherapeutics, Inc. (ATRA), sold 6,679 shares at $0.72 ($5K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Open-market sale of $5k ATRA by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.72 | 1,462 | $1K | 21.9% |
| 2 | $0.72 | 5,217 | $4K | 78.1% |
| Total | $0.72 avg | 6,679 | $5K | 100% |
| Filing → |
| ATRA | SELL | 2024-08-20 | $7K | — | Filing → |
| ATRA | SELL | 2024-05-20 | $18K | — | Filing → |
| ATRA | SELL | 2023-11-20 | $5K | — | Filing → |